BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25205731)

  • 1. Membrane-type I matrix metalloproteinase-dependent ectodomain shedding of mucin16/ CA-125 on ovarian cancer cells modulates adhesion and invasion of peritoneal mesothelium.
    Bruney L; Conley KC; Moss NM; Liu Y; Stack MS
    Biol Chem; 2014 Oct; 395(10):1221-31. PubMed ID: 25205731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.
    Gubbels JA; Belisle J; Onda M; Rancourt C; Migneault M; Ho M; Bera TK; Connor J; Sathyanarayana BK; Lee B; Pastan I; Patankar MS
    Mol Cancer; 2006 Oct; 5(1):50. PubMed ID: 17067392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics.
    Yang J; Kasberg WC; Celo A; Liang Z; Quispe K; Stack MS
    J Biol Chem; 2017 Aug; 292(32):13111-13121. PubMed ID: 28655772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination.
    Moss NM; Barbolina MV; Liu Y; Sun L; Munshi HG; Stack MS
    Cancer Res; 2009 Sep; 69(17):7121-9. PubMed ID: 19706774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression.
    Barbolina MV; Adley BP; Ariztia EV; Liu Y; Stack MS
    J Biol Chem; 2007 Feb; 282(7):4924-4931. PubMed ID: 17158885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
    Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
    Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen.
    Moss NM; Liu Y; Johnson JJ; Debiase P; Jones J; Hudson LG; Munshi HG; Stack MS
    Mol Cancer Res; 2009 Jun; 7(6):809-20. PubMed ID: 19509114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin-linked kinase activity modulates the pro-metastatic behavior of ovarian cancer cells.
    Bruney L; Liu Y; Grisoli A; Ravosa MJ; Stack MS
    Oncotarget; 2016 Apr; 7(16):21968-81. PubMed ID: 26959113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway.
    Matte I; Garde-Granger P; Bessette P; Piché A
    BMC Cancer; 2019 Apr; 19(1):406. PubMed ID: 31039761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3.
    Garg G; Gibbs J; Belt B; Powell MA; Mutch DG; Goedegebuure P; Collins L; Piwnica-Worms D; Hawkins WG; Spitzer D
    BMC Cancer; 2014 Jan; 14():35. PubMed ID: 24447304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion.
    Rump A; Morikawa Y; Tanaka M; Minami S; Umesaki N; Takeuchi M; Miyajima A
    J Biol Chem; 2004 Mar; 279(10):9190-8. PubMed ID: 14676194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse.
    Wang Y; Cheon DJ; Lu Z; Cunningham SL; Chen CM; Luo RZ; Xing D; Orsulic S; Bast RC; Behringer RR
    Differentiation; 2008 Dec; 76(10):1081-92. PubMed ID: 18637025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation.
    Chen SH; Hung WC; Wang P; Paul C; Konstantopoulos K
    Sci Rep; 2013; 3():1870. PubMed ID: 23694968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia promotes HO-8910PM ovarian cancer cell invasion via Snail-mediated MT1-MMP upregulation.
    Sun L; Lin P; Qin Z; Liu Y; Deng LL; Lu C
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1434-45. PubMed ID: 25681470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion.
    Rao TD; Tian H; Ma X; Yan X; Thapi S; Schultz N; Rosales N; Monette S; Wang A; Hyman DM; Levine DA; Solit D; Spriggs DR
    PLoS One; 2015; 10(5):e0126633. PubMed ID: 25965947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.
    Symowicz J; Adley BP; Gleason KJ; Johnson JJ; Ghosh S; Fishman DA; Hudson LG; Stack MS
    Cancer Res; 2007 Mar; 67(5):2030-9. PubMed ID: 17332331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment.
    Coelho R; Marcos-Silva L; Ricardo S; Ponte F; Costa A; Lopes JM; David L
    Expert Rev Anticancer Ther; 2018 Feb; 18(2):177-186. PubMed ID: 29241375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo.
    Zhang MX; Hong SS; Cai QQ; Zhang M; Chen J; Zhang XY; Xu CJ
    Drug Deliv; 2018 Nov; 25(1):797-806. PubMed ID: 29542355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cells.
    Koshikawa N; Mizushima H; Minegishi T; Eguchi F; Yotsumoto F; Nabeshima K; Miyamoto S; Mekada E; Seiki M
    Cancer Sci; 2011 Jan; 102(1):111-6. PubMed ID: 20946474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A binding domain on mesothelin for CA125/MUC16.
    Kaneko O; Gong L; Zhang J; Hansen JK; Hassan R; Lee B; Ho M
    J Biol Chem; 2009 Feb; 284(6):3739-49. PubMed ID: 19075018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.